ZA882391B - Controlling the growth of tumor tissue with chalcone derivatives - Google Patents
Controlling the growth of tumor tissue with chalcone derivativesInfo
- Publication number
- ZA882391B ZA882391B ZA882391A ZA882391A ZA882391B ZA 882391 B ZA882391 B ZA 882391B ZA 882391 A ZA882391 A ZA 882391A ZA 882391 A ZA882391 A ZA 882391A ZA 882391 B ZA882391 B ZA 882391B
- Authority
- ZA
- South Africa
- Prior art keywords
- growth
- tumor tissue
- controlling
- chalcone derivatives
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/036,227 US4904697A (en) | 1987-04-09 | 1987-04-09 | Controlling the growth of certain tumor tissue with chalcone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA882391B true ZA882391B (en) | 1988-09-23 |
Family
ID=21887400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA882391A ZA882391B (en) | 1987-04-09 | 1988-04-05 | Controlling the growth of tumor tissue with chalcone derivatives |
Country Status (8)
Country | Link |
---|---|
US (1) | US4904697A (de) |
EP (1) | EP0288794B1 (de) |
KR (1) | KR880012217A (de) |
AT (1) | ATE106723T1 (de) |
AU (1) | AU599220B2 (de) |
DE (1) | DE3889970T2 (de) |
PH (1) | PH25183A (de) |
ZA (1) | ZA882391B (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4753965A (en) * | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
AU634921B2 (en) * | 1990-12-25 | 1993-03-04 | Ohgen Research Laboratories Ltd. | Deacetylcolchicine derivatives |
WO1993006860A1 (en) * | 1991-10-07 | 1993-04-15 | The Cancer Immunology Research Corporation | Treatment of premalignant and malignant lesions |
JPH07502274A (ja) * | 1991-12-10 | 1995-03-09 | ラシユ−プレスビタリアン−セントルークス・メデイカル・センター | 多薬剤耐性を低下させる方法および組成物 |
US5681812A (en) * | 1991-12-10 | 1997-10-28 | Rush Presbyterian-St. Luke's Medical Center | Methods and compositions for reducing multidrug resistance |
US5952355A (en) * | 1993-11-17 | 1999-09-14 | Kyowa Hakko Kogyo Co., Ltd. | Propenone derivatives |
IL112205A0 (en) * | 1994-01-06 | 1995-03-15 | Res Dev Foundation | Curcumin, analogues of curcumin and novel uses thereof |
GB9401891D0 (en) * | 1994-02-01 | 1994-03-30 | Boots Co Plc | Therapeutic agents |
US5834442A (en) * | 1994-07-07 | 1998-11-10 | Barbara Ann Karmanos Cancer Institute | Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
EP0770601A4 (de) * | 1995-05-10 | 1998-08-05 | Kyowa Hakko Kogyo Kk | Propenon-derivate |
IL121789A (en) * | 1996-10-03 | 2001-06-14 | Rohm & Haas | A medicinal product for inhibiting mammalian cell tumors |
AU771994B2 (en) * | 1996-12-02 | 2004-04-08 | Ipxmedical, Llc | Compositions and methods for treating or preventing inflammatory diseases |
AU2004200715B2 (en) * | 1996-12-02 | 2006-08-31 | Angiotech International Ag | Compositions and methods for treating or preventing inflammatory diseases |
US20030157187A1 (en) * | 1996-12-02 | 2003-08-21 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory diseases |
US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
EP0947511A1 (de) * | 1998-03-30 | 1999-10-06 | F. Hoffmann-La Roche Ag | Phenoxy-Essigsäurederivate und Phenoxymetyl-Tetrazolderivate mit antitumoraler Wirkung |
EP0947494A1 (de) * | 1998-03-30 | 1999-10-06 | F. Hoffmann-La Roche Ag | Phenoxyessigsäure- und Phenoxymethyltetrazolderivate mit Antitumoraktivität |
CA2413878A1 (en) | 2000-06-20 | 2001-12-27 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
CA2428753C (en) | 2000-11-17 | 2013-05-21 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
FR2817749A1 (fr) * | 2000-12-13 | 2002-06-14 | Aventis Pharma Sa | Nouvelle utilisation des composes de la classe des chalcones |
GB0126889D0 (en) * | 2001-11-08 | 2002-01-02 | Paterson Inst For Cancer Res | Compounds and their uses |
FR2833004B1 (fr) * | 2001-12-05 | 2004-12-10 | Aventis Pharma Sa | Aryl-cycloalcaines substitues, compositions les contenant et utilisation |
PE20030758A1 (es) * | 2001-12-05 | 2003-10-07 | Aventis Pharma Sa | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion |
FR2833008B1 (fr) * | 2001-12-05 | 2004-05-21 | Aventis Pharma Sa | 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation |
US20040147584A2 (en) * | 2001-12-05 | 2004-07-29 | Aventis Pharma S.A. | 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof |
RU2004121898A (ru) * | 2001-12-19 | 2006-01-20 | Атеродженикс, Инк. (Us) | Производные халкона и их применение для лечения заболеваний |
AU2002342808A1 (en) * | 2002-10-09 | 2004-05-04 | Unibioscreen S.A. | Extract with anti-tumor and anti-poisonous activity |
AU2003303239A1 (en) * | 2002-12-19 | 2004-07-14 | Atherogenics, Inc. | Process of making chalcone derivatives |
US7326734B2 (en) * | 2003-04-01 | 2008-02-05 | The Regents Of The University Of California | Treatment of bladder and urinary tract cancers |
US20050249667A1 (en) * | 2004-03-24 | 2005-11-10 | Tuszynski Jack A | Process for treating a biological organism |
WO2006004903A2 (en) * | 2004-06-28 | 2006-01-12 | Atherogenics, Inc. | 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof |
AU2015324072B2 (en) * | 2014-09-29 | 2018-12-06 | The Penn State Research Foundation | A compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 |
US11746104B2 (en) | 2019-06-13 | 2023-09-05 | Qatar University | Chalcone-based chemotherapeutic compound for triple negative breast cancer |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL131029C (de) * | 1959-08-20 | |||
US3808006A (en) * | 1971-12-06 | 1974-04-30 | Minnesota Mining & Mfg | Photosensitive material containing a diaryliodium compound, a sensitizer and a color former |
US3729313A (en) * | 1971-12-06 | 1973-04-24 | Minnesota Mining & Mfg | Novel photosensitive systems comprising diaryliodonium compounds and their use |
DE2602419A1 (de) * | 1976-01-23 | 1977-07-28 | Basf Ag | Photopolymerisierbare masse |
JPS6026122B2 (ja) * | 1977-01-20 | 1985-06-21 | 富士写真フイルム株式会社 | 光重合性組成物 |
US4162162A (en) * | 1978-05-08 | 1979-07-24 | E. I. Du Pont De Nemours And Company | Derivatives of aryl ketones and p-dialkyl-aminoarylaldehydes as visible sensitizers of photopolymerizable compositions |
JPS54152091A (en) * | 1978-05-22 | 1979-11-29 | Fuji Photo Film Co Ltd | Photopolymerizable composition |
US4279930A (en) * | 1978-10-10 | 1981-07-21 | The Upjohn Company | Process for treating inflammation |
NZ192641A (en) * | 1979-01-26 | 1984-10-19 | Hoffmann La Roche | Substituted acetophenones and pharmaceutical compositions |
EP0028305B1 (de) * | 1979-09-13 | 1984-02-01 | The Wellcome Foundation Limited | Diarylverbindungen und diese enthaltende pharmazeutische Zusammensetzungen |
CA1168659A (fr) * | 1980-08-06 | 1984-06-05 | Gerard Lang | Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant |
US4753965A (en) * | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
-
1987
- 1987-04-09 US US07/036,227 patent/US4904697A/en not_active Expired - Fee Related
-
1988
- 1988-04-05 PH PH36739A patent/PH25183A/en unknown
- 1988-04-05 ZA ZA882391A patent/ZA882391B/xx unknown
- 1988-04-05 AU AU14164/88A patent/AU599220B2/en not_active Ceased
- 1988-04-07 AT AT88105540T patent/ATE106723T1/de not_active IP Right Cessation
- 1988-04-07 EP EP88105540A patent/EP0288794B1/de not_active Expired - Lifetime
- 1988-04-07 DE DE3889970T patent/DE3889970T2/de not_active Expired - Fee Related
- 1988-04-08 KR KR1019880003946A patent/KR880012217A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU599220B2 (en) | 1990-07-12 |
EP0288794A2 (de) | 1988-11-02 |
AU1416488A (en) | 1988-10-13 |
DE3889970D1 (de) | 1994-07-14 |
PH25183A (en) | 1991-03-27 |
KR880012217A (ko) | 1988-11-26 |
EP0288794A3 (en) | 1988-11-23 |
ATE106723T1 (de) | 1994-06-15 |
EP0288794B1 (de) | 1994-06-08 |
DE3889970T2 (de) | 1994-10-06 |
US4904697A (en) | 1990-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH25183A (en) | Controlling the growth of certain tumor tissue with chalcone derivatives | |
AU1416688A (en) | Method of treating multiple sclerosis with chalcone derivatives | |
AU574350B2 (en) | Human nerve growth factor by recombinant technology | |
AU6998787A (en) | Transglutaminase inhibitors | |
AU633274B2 (en) | Method for controlling the growth of non-osseous non-cartilaginous solid connective tissue | |
DE3885883D1 (de) | Vorrichtung zur sollwertregelung und/oder stabilisierung von freibeweglichen körpern mit gespeichertem drall. | |
ATE286125T1 (de) | Regulation der genexpression von bcl-2 | |
AU2883689A (en) | The use of moclobemide to treat or prevent cognitive disorders | |
DE68922974D1 (de) | Verwendung von Hydroxycarbonsäuren zur Stabilisation von Bisphenolen. | |
ATE90568T1 (de) | Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen. | |
MY106615A (en) | Stabilized leukocyte-interferons. | |
HUT47033A (en) | Process for production of medical compositions against tumor | |
DE59100964D1 (de) | Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
AU1416588A (en) | Methods of treating gout with chalcone derivatives | |
AU7999687A (en) | Active compounds for preventing tumor metastases | |
AU3439889A (en) | Improvements relating to the control of neoplastic tissue growth | |
IL89901A0 (en) | Strobilurine derivatives | |
AU1496988A (en) | Porcine growth hormone analogs | |
IE881077L (en) | Controlling the growth of tumor tissue with chalcone¹derivatives | |
ZA884012B (en) | Tissue plasminogen activator analogs having modified growth factor domains | |
DE3478745D1 (en) | 6h-dibenz (b,e)(1,4)oxathiepin compounds | |
AU580646B2 (en) | 13``-alkyl-17``-(3-aceloxy-propyl)-gonane | |
ATA167589A (de) | Verfahren zur wuchsregulierung von wiesengesellschaften | |
ATE69137T1 (de) | Stabilisiertes gossyplure und verfahren zu dessen herstellung. |